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Antioxidative enzyme activities in human
erythrocytes
Helle Raun Andersen,* Jesper B. Nielsen, Flemming Nielsen, and Philippe Grandjean
Reliable and standardized methods are necessary to
determine the expression of antioxidative enzymes and
their role in maintaining health. In addition, the vari-
ability of the enzyme activities within the general pop-
ulation caused by age, gender, and life-style factors
must be described. This study describes methodological
conditions that are suitable for analyzing copper–zinc
superoxide dismutase (CuZn-SOD), glutathione peroxi-
dase (GSH-Px), catalase (CAT), and glutathione reduc-
tase (GR) in human erythrocytes with a high degree of
reproducibility. Intervals for the enzyme activities have
been established in a randomly selected population of
220 individuals between 20 and 89 years of age. An
age-related decrease was observed in CuZn-SOD and
GR activities, whereas no age-related changes were
demonstrated for GSH-Px and CAT. The GSH-Px activ-
ity was positively associated with the intake of dietary
supplements and negatively correlated with tobacco
consumption. These factors probably account for the
fact that women tended to have higher GSH-Px activity.
INDEXING TERMS: superoxide dismutase • glutathione per-
oxidase • glutahione reductase • catalase • biological
variability
Detrimental effects caused by reactive oxygen species
occur as a consequence of an imbalance between the
formation and inactivation of these species. Oxidative
damage may be involved in the pathogenesis of major
diseases such as cancer, atherosclerosis [1], and certain
neurological disorders [2]. Inactivation and removal of
reactive oxygen species depend on reactions involving the
antioxidative defense system. The capacity is determined
by a dynamic interaction between individual compo-
nents, which include vitamins A, E, and C, b-carotene,
reduced glutathione (GSH), and several antioxidative
enzymes.1 The most important enzymatic antioxidants are
superoxide dismutase (CuZn-SOD; EC 1.15.1.1), which
catalyzes dismutation of the superoxide anion (O2z
2) into
H2O2, which is then deactivated to H2O by catalase (CAT;
EC 1.11.1.6) and glutathione peroxidase (GSH-Px; EC
1.11.1.9). GSH-Px also reduces organic peroxides into
their corresponding alcohols. GSH-Px uses GSH as a
hydrogen donor whereby GSH is oxidized. The regener-
ation of GSH is catalyzed by glutathione reductase (GR;
EC 1.6.4.2).
Wide interindividual variations may exist regarding
antioxidative capacity, thus affecting individual suscepti-
bility against deleterious oxidative reactions. However,
very limited information exists concerning the biological
variation of antioxidative enzymes in representative pop-
ulation samples. This study presents intervals for antioxi-
dative enzyme activities from a randomly selected popu-
lation. All enzyme activities except CAT were measured
by automated methods.
Materials and Methods
human subjects
The sample group consisted of 220 individuals (110
women and 110 men) randomly selected from the Danish
central registry of residents by using the following crite-
ria: 20 men and 20 women in each age decade between 20
and 89 years, half of them residing within the city and the
other half within rural communities. No exclusion criteria
were used. Participants were included consecutively, after
signing an informed consent form, until their respective
subgroups were filled as described in a previous study
[3]. The overall response and participation rates were 70%
and 31% respectively. The participation rate was particu-
larly low in the two oldest age decades (6% and 19%), and
the anticipated number of subjects was not obtained in
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these two age decades. Information regarding dietary
habits, use of dietary supplements, alcohol consumption,
smoking, drug intake, working conditions, hobbies, and
housing situations were obtained by interview. Approxi-
mately 60% of the sample group was currently employed.
Other participants were students, retirees, or unem-
ployed. Forty-three per cent were current smokers, 23%
were ex-smokers, and 32% had never smoked. According
to these data, the sample group does not seem to deviate
from the general population [4, 5].
To estimate within-subject variations and the effect of
fasting and food intake, six healthy volunteers twice
delivered blood samples three successive days and there-
after three times once a week. One week later, the six
volunteers delivered a fasting blood sample. After this
blood sampling a substantial breakfast rich in fat and
protein was consumed by all subjects. One hour after this
meal a new blood sample was drawn. To investigate the
effect of different anticoagulants, venous blood samples
from two volunteers were collected into Venoject tubes
(VT-100 TK; Terumo, Leuven, Belgium) containing either
Na-heparin or K3-EDTA. To minimize the influence of
analytical variation, all samples from each individual
were analyzed in the same analytical run.
The study followed the guidelines of the Second Hel-
sinki declaration and was approved by the Regional
ethical review committee.
blood samples
Venous blood samples were collected from all study
subjects into Venoject tubes with EDTA (0.47 mol/L
K3-EDTA) between 1000 and 1800. All individuals were
placed in a reclining position for a minimum of 10 min
before blood sampling by the same phlebotomist. Within
4 h after sampling, the blood was centrifuged at 1000g for
10 min to separate the plasma. The buffy coat was
removed and the remaining erythrocytes were drawn
from the bottom, washed three times in cold saline (9.0
g/L NaCl), and hemolyzed by adding the same weight of
ice-cold demineralized ultrapure (MilliQ plus reagent
grade; Millipore, Bedford, MA) water to yield a 50%
hemolysate. The hemolysates were frozen in 500-mL ali-
quots at 280 °C for later analysis.
Erythrocytes isolated from blood samples delivered
from 20 healthy blood donors were pooled and hemo-
lyzed after the washing procedure to obtain identical
aliquots to be used as control material.
analytical methods
All reagents used were analytical grade. Water used was
demineralized ultrapure of MilliQ plus reagent grade. All
reagents except the phosphate buffers were prepared each
day and stored in a refrigerator at 24 °C. The reagents
were equilibrated at room temperature for 0.5 h before
use when the analysis was initiated or reagent containers
were refilled. Phosphate buffers were stable at 24 °C for 1
month. At the day of analysis the hemolysates were
thawed and diluted 5:1 (by vol) with distilled water and
further 2:1 (by vol) with a phosphate buffer containing
dithiothreitol (DTT) (100 mmol/L KH2PO4, 1 mmol/L
EDTA, 2 mmol/L DTT, pH 7.4) to a final dilution of 1:20.
These 1:20 hemolysates were used for all analyses. Di-
luted samples not analyzed immediately were placed in a
refrigerator until analysis later in the day. Protein (Pr) and
hemoglobin (Hb) concentrations and all enzyme activities
except CAT were determined with a Cobas Mira autoana-
lyzer (F. Hoffmann-La Roche, Diagnostic Systems, Basle,
Switzerland). The methods were modified as stated below
for the autoanalyzer procedure. To obtain optimal accu-
racy in pipetting, small volumes of H2O or assay buffer
were pipetted into the cuvettes together with samples and
reagents to rinse the needle. These volumes are included
in the final reaction volumes. All measurements were
performed in triplicate.
Assay of CuZn-SOD activity. Determination of CuZn-SOD
activity was performed by using a kit (Ransod; Randox
Labs. cat. no. SD 125, Crumlin, UK) based on the method
developed by McCord and Fridovich [6] coupling an O2z
2
generator with an O2z
2 detector. In the kit, xanthine and
xanthine oxidase are used to generate O2z
2 and 2-(4-
iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chlo-
ride (INT), which reacts with O2z
2 to form a red formazan
dye used as detector. CuZn-SOD inhibits the formation of
the formazan dye, and the activity is measured as percent
inhibition compared with a calibration curve with puri-
fied SOD. The final concentrations of the reagents used in
the assay were as recommended by the manufacturer
(0.05 mmol/L xanthine and 0.025 mmol/L INT in the
main reagent and 80 U/L xanthine oxidase in the start
reagent). The sample (1:20 hemolysate) was first diluted
10-fold in KH2PO4 buffer (10 mmol/L; pH 7.0) by the
autoanalyzer and 5 mL (plus 20 mL of H2O) of diluted
hemolysate was added concomitantly with the main re-
agent (170 mL) to the cuvette. Absorbance was monitored
at 500 nm for 150 s after addition of xanthine oxidase (25
mL plus 10 mL of H2O) as start reagent. The final reaction
volume was 230 mL. The unit of activity is defined as the
amount of enzyme that inhibits the rate of the formazan
dye formation by 50%.
Assay of GSH-Px activity. Total activity of GSH-Px was
determined by the coupled enzyme procedure [7] with
tert-butyl hydroperoxide as substrate. In erythrocytes
from adult humans all GSH-Px activity seems to be Se
dependent [8] and therefore the measurements represent
Se-dependent GSH-Px activity. Before analysis the auto-
analyzer was programmed to dilute the sample 10-fold to
a 1:200 hemolysate by adding Drabkin’s reagent (double
strength) to inhibit the peroxidase activity of Hb. The
main reagent was made by mixing 8.00 mL of KH2PO4
buffer (100 mmol/L; 1 mmol EDTA/L; pH 7.4), 4.00 mL of
GR (5000 U/L, cat. no. G-4751; Sigma Chemical Co., St.
Louis, MO), 2.00 mL of GSH (2.5 mmol/L; Sigma G-4251),
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and 2.00 mL of NADPH (2.5 mmol/L; Sigma N-1630). The
main reagent (200 mL) and the sample (25 mL of 1:200
hemolysate plus 10 mL of H2O) were added to the cuvette
and the absorbance at 340 nm was monitored for 200 s
(step A). Then 10 mL of tert-butyl hydroperoxide (25
mmol/L; Sigma B-2633) (plus 5 mL of H2O) were added as
start reagent. The absorbance was monitored for another
225 s (step B). The final reaction volume was 250 mL. The
difference in absorbance per minute between steps B and
A was used to calculate the enzyme activity by using a
molar absorptivity of NADPH at 6.22 3 103 L mol21 cm21.
The unit is mmol of NADPH oxidized/min.
Assay of GR activity. Activity was determined by following
the oxidation of NADPH to NADP1 during the reduction
of oxidized glutathione (GSSG) [9]. The main reagent was
prepared by combining 18.00 mL of KH2PO4 buffer (139
mmol/L, 0.76 mmol/L EDTA; pH 7.4) and 2.00 mL of
NADPH (2.5 mmol/L). The sample (20 mL of 1:20 hemo-
lysate plus 20 mL of KH2PO4 buffer), 220 mL of the main
reagent, and 5 mL of FAD (315 mmol/L) plus 10 mL of
KH2PO4 buffer were added to the cuvette, and the absor-
bance at 340 nm was monitored for 200 s (step A). Then 30
mL of GSSG (22 mmol/L; Sigma G-4376) plus 10 mL of
KH2PO4 buffer were added to start the reaction and the
absorbance was followed for 175 s. The final reaction
volume was 315 mL. The difference in absorbance per
minute between steps B and A was used to calculate the
enzyme activity by using a molar absorptivity of NADPH
at 6.22 3 103 L mol21 cm21. The unit is mmol of NADPH
oxidized/min.
Assay of CAT activity. CAT activity was determined by the
method described by Aebi [10] by using a UV/visible
spectrophotometer (lambda 11; Perkin-Elmer, Norwalk,
CT). The decomposition rate of the substrate H2O2 was
monitored at 240 nm. A molar absorptivity of 43.6 L
mol21 cm21 was used to calculate the activity. One unit is
equal to 1 mmol of H2O2 decomposed/min.
Hb and Pr concentrations. Hb and Pr concentrations in the
1:20 hemolysates were determined spectrophotometri-
cally on the Cobas Mira by standard kits. The Hb assay
(Sigma cat. no. 525-A) is based on the colorimetric cya-
nomethemoglobin method, and the Pr assay (Sigma cat.
no. 541–2) is based on the colorimetric biuret method. The
specific enzyme activities were expressed as U/g Hb or
U/g Pr.
Quality assurance. For all enzymes, identical samples of
control material were analyzed repeatedly during each
day to adjust for analytical day-to-day variations.
statistics
Statistical analyses were performed by using the SPSS 6.0
software (SPSS, Chicago, IL). Goodness of fit to normal
distributions were investigated by probit plots and the
Lilliefors test. GSH-Px and CAT values showed normal
distributions. The logarithmic transformation of CuZn-
SOD and GR results also approached the normal distri-
bution. Multiple regression analysis with backward elim-
ination was used to investigate the influence of different
variables on the enzyme activities. The criterion for re-
moving variables from the model was chosen at P .0.10.
Spearman’s rank correlation coefficient was used to inves-
tigate associations between enzyme activities. Differences
in means between groups were analyzed by the indepen-
dent-samples t-test. The effects of fasting and eating on
enzyme activities were analyzed by paired t-test. Intervals
for the enzyme activities were established by using the
program REFVAL 3.42. This program implements the
methods for statistical treatment of reference values rec-
ommended by the IFCC. Two-tailed P values are given
throughout.
Results
The precision of the analytical methods was assessed by
repeated assays of pools of hemolysates. The CVs for
within-day repeatability and day-to-day reproducibility
are shown in Table 1. Within-run CVs express the preci-
sion of the autoanalyzer. Since CAT activity was mea-
sured by a manual assay, no within-run CV for CAT is
available. The within-run CVs obtained for the enzyme
analysis on the autoanalyzer by measuring 10 consecutive
aliquots of a sample were always ,3%. The within-day
variations ranged between 2.1% and 6.5% for the various
enzyme analyses. The highest day-to-day variations were
seen for CuZn-SOD and GSH-Px. To minimize the influ-
ence of analytical variations, the values measured were
adjusted by using the control samples as internal stan-
dards. Thus the day-to-day variations for CuZn-SOD,
GSH-Px, and GR were reduced considerably (Table 1).
Within-day CVs for Hb and Pr determinations were ,1%
and ,2% and day-to-day CVs ,3.5% and ,2.5% respec-
tively. No storage-related changes in mean enzyme activ-
ities were observed for up to 6 months at 280 °C. The
enzyme activities in the control hemolysates were there-
fore considered stable.
The activities of the four antioxidative enzymes ob-
tained in this study are shown in Table 2. The results of
the statistical analysis were independent of whether the
enzyme activities were expressed per gram of Pr or gram
of Hb. All enzyme activities were independent of whether
the study person was fasting or not and whether the
blood samples were collected into tubes containing Na-
heparin or K3-EDTA as anticoagulant.
The within-subject variations are shown in Table 3. The
between-subject variations for the 220 subjects in the
sample group were 11.1% for CuZn-SOD, 16.6% for
GSH-Px, 12.3% for GR, and 9.4% for CAT. Thus, the mean
within-subject variation is approximately half as large for
all of these enzymes. The highest within-subject variations
for CuZn-SOD and GSH-Px were almost as large as the
between-subject variation.
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The covariates included in the regression model were
age (years), gender (0 5 men, 1 5 women), smoking (0 5
no, 1 5 yes), tobacco consumption (g/day), alcohol
(drinks/week), caffeine intake (cups of coffee/day; 1 cup
of tea 5 1⁄2 cup of coffee), and dietary supplements (0 5
no, 1 5 yes).
Use of drugs within the last month was reported by 83
individuals. Of these, 32 had used more than one drug.
The drugs were classified according to WHO [11] and the
most frequently used types of drugs were sex hormones
including oral contraceptives (n 5 28), analgesics (n 5 26),
nonsteroidal antiinflammatory drugs (n 5 12), diuretics
(n 5 11), psycholeptics (n 5 9), antiasthmatics (n 5 8),
antibacterials (n 5 6), and calcium channel blockers (n 5
5). Other drug types were used by less than five individ-
uals. Drug treatment was not included in the regression
model since most drug types were only used by a few
individuals. In addition, it is not possible in this study to
separate effects from drug treatment from effects of the
disease on enzyme activities. When means of enzyme
activities were compared between groups using specific
drugs types and individuals using no drugs, a tendency
towards higher GR activity was observed among users of
analgesics (P 5 0.06). Only groups consisting of 10 or
more individuals were analyzed. No other drug-related
effects on enzyme activities were observed.
The activity of CuZn-SOD significantly decreased with
age (Table 4, Fig. 1). None of the other variables recorded
had any significant effect on the CuZn-SOD activity.
In contrast, no age relation was found for GSH-Px.
Daily intake of dietary supplements was associated with
an increased activity of GSH-Px, whereas the amount of
tobacco consumption was negatively correlated with
GSH-Px activity (Table 4). GSH-Px activity was slightly
higher in women than in men (Table 4; Fig. 1). Women
used dietary supplements more frequently than men
(43.6% and 27.5% respectively); therefore the effects of
dietary supplements and gender on GSH-Px activity are
difficult to separate. However, the tolerance was high
(0.97) and variance inflation factor low (1.03) for gender in
the final regression model, indicating separate influence
on the variance from the two variables. The mean activity
of GSH-Px was significantly lower in current smokers
than in nonsmokers (P 5 0.028). However, some of this
difference may be explained by a tendency toward fewer
users of dietary supplements among smokers and a
higher level of tobacco consumption among men than
women (data not shown). Thus, according to the regres-
sion analysis, smoking was not significantly associated
with GSH-Px activity when adjustment for other variables
was included (Table 4).
The activity of GR decreased slightly with age (Table 4;
Fig. 1) and with smoking.
The activity of CAT was not appreciably influenced by
any of these variables. The CAT activity as a function of
age for both sexes is shown in Fig. 1. Alcohol and caffeine
intake were not associated with any of the enzyme
activities.
The activity of CuZn-SOD was positively correlated to
CAT (r 5 0.26; P ,0.0001) and GR (r 5 0.16; P 5 0.02), and
CAT was positively correlated to GR (r 5 0.21; P 5 0.002).
No significant correlations were found between GSH-Px
and any of the other enzymes measured.
Discussion
Antioxidative enzymes may play an important role in
determining individual risk of developing certain dis-
eases, such as cancer or atherosclerosis. Besides constitu-
tional individual differences in gene expression, antioxi-
dative enzyme activities apparently depend on variations
in life-style and environmental factors, since within-sub-
ject variations are greater than the analytical imprecision.
The relatively high analytical variations of CuZn-SOD
and GSH-Px is probably caused by unavoidable differ-
ences in manual weighing and pipetting of reagents as
Table 1. CVs for antioxidative enzyme measurements
in erythrocytes.
CuZn-SOD, U/L CAT, kU/L GSH-Px, U/L GR, U/L
Within-run
n 10 10 10
Mean 8531 1545.6 146.3
CV, % 2.7 3.0 2.1
Within-day
n 16 12 12 12
Mean 10683 2179.6 1712.6 142.0
CV, % 6.5 2.8 4.9 2.1
Day-to-day
n 12 7 11 11
Mean 11314 2204.2 1693.9 141.7
CV, % 5.6 3.7 5.7 2.8
Meana 11384 2085.3 1570.9 123.2
CV, %a 4.3 4.0 4.8 1.6
a After adjustment for analytical day-to-day variations by including identical
samples of control material in each analytical run.
Table 2. Enzyme activities of CuZn-SOD, GSH-Px, GR, and
CAT in erythrocytes for 220 individuals (both sexes)
between 20 and 89 years of age.
Enzyme
0.025 Fractile
(0.90 confidence interval)
0.975 Fractile
(0.90 confidence interval)
CuZn-SOD
U/g Pr 418 (408–429) 655 (637–674)
U/g Hb 748 (732–764) 1194 (1162–1226)
GSH-Px
U/g Pr 47.08 (45.21–48.97) 91.68 (88.98–94.47)
U/g Hb 86.32 (83.13–89.55) 165.55 (160.47–170.84)
GR
U/g Pr 3.48 (3.35–3.61) 5.81 (5.63–6.00)
U/g Hb 6.30 (6.08–6.52) 10.33 (10.05–10.64)
CAT
kU/g Pr 73.14 (71.78–74.53) 106.01 (104.08–108.00)
kU/g Hb 130.36 (127.76–132.99) 192.27 (188.52–196.13)
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well as small variations between kits. The methods used
for measuring CAT and GR are less sensitive to small
variations in reagent concentrations, since the reagents
added in these assays are not rate limiting.
Antioxidative enzyme activities vary among different
tissues, and environmental factors might affect the en-
zyme activities only in susceptible organs. Therefore, the
activities found in erythrocytes do not necessarily reflect
the antioxidative defense of the whole organism. In this
study, variations between individuals are generally sub-
stantially larger than within-subject variations, thus sug-
gesting that the enzyme activity in a blood sample may
reflect differences in the antioxidative defense.
Most previous studies were designed to compare ac-
tivities of antioxidative enzymes in groups of patients
with certain diseases with matched controls. Observed
differences in enzyme activities in most of these studies
could constitute a contributory cause of the disease, a
result of the disease, or an effect of drug treatment. In
addition, analytical differences between laboratories
make it difficult to compare the results obtained in
different studies. Although most laboratories use meth-
ods based on the same methodological principles, the
specific assay conditions regarding concentration of re-
agents, recording time, and temperature differ.
A small number of other studies have addressed the
biological variability in antioxidative enzymes [12–14].
However, these studies are apparently not based on
randomly selected population groups. In the present
study, an age-related decrease was observed in CuZn-
SOD and GR activities in erythrocytes. No obvious age-
related changes were observed for CAT or GSH-Px,
although GSH-Px tended to increase slightly with age.
These results are in accordance with a French study [12]
based on 167 individuals between 1 month and 67 years of
age; a negative correlation between age and activities of
CuZn-SOD and GR and a positive correlation between
age and GSH-Px activity in erythrocytes were reported. In
another French study [13] involving 1782 individuals
between 4 and 65 years of age and 54 subjects between 65
and 97 years, the activities of CuZn-SOD, CAT, and
GSH-Px in erythrocytes decreased with age, especially in
individuals .65 years of age. GR was not investigated. An
age-related decrease in CuZn-SOD activity in erythro-
cytes was also reported from a Polish population (n 5 93)
between 4 and 80 years of age, and the activities of CAT
and GSH-Px increased with age [14]. Hence, an age-
related decrease in CuZn-SOD activity in human erythro-
cytes seems to be a rather consistent finding, whereas
some discrepancy exists regarding the age relation of the
other antioxidative enzymes. Some differences between
the studies may be due to factors other than age, since
random population samples were not used, and selection
bias may have affected the results.
Of the enzymes investigated, GSH-Px seems to be most
clearly influenced by life-style and environmental factors,
as indicated in this study by intake of dietary supple-
ments and smoking habits. In other studies, smoking
Table 3. Within-subject variations of CuZn-SOD, GSH-Px, GR, and CAT activities in erythrocytes in six healthy volunteers.a
Subject
no.
CuZn-SOD, U/g Pr GSH-Px, U/g Pr GR, U/g Pr CAT, kU/g Pr
Mean CV, % Mean CV, % Mean CV, % Mean CV, %
1 372 3.8 52.8 4.4 4.5 4.0 74.5 2.9
2 470 7.5 78.6 4.4 4.5 3.5 87.4 5.7
3 446 6.4 46.4 4.9 4.0 3.5 71.6 4.7
4 420 6.6 43.8 5.3 4.8 7.0 71.9 5.1
5 434 4.9 46.3 10.6 3.6 6.9 67.2 4.7
6 386 9.4 35.5 13.0 3.8 5.9 66.5 4.6
a Nine blood samples from each individual delivered twice three successive days and thereafter three times once a week.
Table 4. Multiple regression analysis of antioxidative enzyme activities in erythrocytes and potential determinant variables.
Variables
ln CuZn-SOD, U/g Pr GSH-Px, U/g Pr ln GR, U/g Pr
B (SE)a P B (SE) P B (SE) P
Age 20.001
(0.0005)
0.015 — 20.001
(0.0005)
0.066
Gender — 2.55 (1.51) 0.092 —
Tobacco consumption — 20.21 (0.02) 0.025 —
Smoking — — 20.03 (0.02) 0.075
Dietary supplements — 3.69 (1.58) 0.020 —
Intercept 6.31 66.56 1.57
Adjusted R2 0.023 0.061 0.023
R SE 0.108 10.85 0.122
a Regression coefficient (standard error).
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habits did not influence GSH-Px activity in erythrocytes
[13, 15], but a decreased activity of GSH-Px in plasma has
been observed in smokers [16]. The higher GSH-Px activ-
ity among users of dietary supplements is probably due to
higher Se intake from supplements containing minerals
[17]. A significantly higher GSH-Px activity in women
than in men has been found in some studies [13, 18] but
not in others [12]. In the present study, women tended to
have higher GSH-Px activity, but the small difference
could be due to chance or to gender-related differences in
life-style such as intake of dietary supplements.
Measurement of antioxidative vitamins and other es-
sential nutrients in human blood samples has been rec-
ommended to assess the optimal intake [19]. However,
the application of measurements of antioxidative factors
has yet to be elucidated in greater detail. First, reliable
methods to measure antioxidative enzymes as well as
other antioxidants in human blood samples have to be
established and standardized. In addition, the variation in
antioxidant concentrations in the general population and
the influence of age, gender, life-style, and dietary and
environmental factors on these parameters have to be
estimated before the role of antioxidants in disease pre-
vention can be further investigated.
In conclusion, this study describes measurement condi-
tions that are suitable and reliable for analyzing antioxi-
dative enzymes in human erythrocytes with a high degree
of reproducibility. The advantages of using automated
assays include reduced analytical variation, considerable
reductions in time, and smaller sample volumes, when
compared with manual assays. Intervals for antioxidative
enzyme activities in erythrocytes from a randomly se-
lected population have been established. These results can
be used in the process of defining reference intervals for
the antioxidative enzymes. Depending on the intended
Fig.1. Scatterplot of ln CuZn-SOD (A), GSH-Px (B), ln GR (C), and CAT (D) activities against age.
f, (- - - -), men; S, (. . . . ), women; ( ), total population.
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use of these reference intervals, the influence of age,
gender, state of health, and life-style factors on the en-
zyme activities should be considered.
We acknowledge Jan Beyer and Birgit Larsen for excellent
technical assistance. The study was supported by the
Danish Strategic Environmental Research Program fi-
nanced by the Danish Goverment.
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